NASDAQ
Avai Bio, Inc. (AVAI) has a free cash flow growth of 6.57% as of Friday, May 29, 2026. This represents a 168.11% increase compared to its 12-month average of -9.65%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.